Commentary|Videos|January 13, 2025
In Migraine Research, Placebo Effect is Increasingly Reaching Parity with Study Drug Impact: Experts Say, "What?"
Author(s)Peter McAllister, MD, Grace Halsey
Migraine expert Peter McAllister, MD, a long-time principal investigator for migraine studies, wonders if study design in this area needs to be re-evaluated.
Advertisement
Peter McAllister, MD, is associate professor of neurology at the Yale University School of Medicine, in New Haven, CT and co-founder and medical director of the New England Institute for Neurology and Headache, chief medical officer of New England Institute for Clinical Research and Ki Clinical Research, president and chief executive officer of Ki Management Services, in Stamford CT.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
ACOG Releases New Guidance on HIV Screening and Prevention
2
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
3
From Amyloid Clearance to Daytime Function: Why Sleep Quality Matters for Brain Health
4
FDA Accepts Cefiderocol sNDA for Pediatric Gram-Negative Infections
5


























































































































































